PolarCool boosted by 5-year clinical study results
Medtech company PolarCool has developed PolarCap, a medical device that actively cools down the brain in the acute phase of an injury to decrease concussion symptoms. Results from a 5-year clinical study with the device have just been published in the Journal of Neurotrauma, and PolarCool’s CEO Erik Andersson stopped by the BioStock Studio to discuss the results.
Watch the interview with PolarCool‘s CEO Erik Andersson below:
The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.
